<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <funding-statement>The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under the project “European Management Platform for Emerging and Re-emerging Infectious disease Entities” (EMPERIE) EC grant agreement number 223498 and the VIRGO Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
